BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 3336461)

  • 1. Genetic factors in myasthenia gravis: a family study.
    Kerzin-Storrar L; Metcalfe RA; Dyer PA; Kowalska G; Ferguson I; Harris R
    Neurology; 1988 Jan; 38(1):38-42. PubMed ID: 3336461
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immunogenetic heterogeneity and associated autoimmune disorders in myasthenia gravis: a population-based survey in the province of Ferrara, northern Italy.
    Tola MR; Caniatti LM; Casetta I; Granieri E; Conighi C; Quatrale R; Monetti VC; Paolino E; Govoni V; Pascarella R
    Acta Neurol Scand; 1994 Nov; 90(5):318-23. PubMed ID: 7887131
    [TBL] [Abstract][Full Text] [Related]  

  • 3. HLA antigens and susceptibility to myasthenia gravis.
    Matej H; Nowakowska B; Kałamarz M; Paradowski B; Podemski R; Brzecki A
    Arch Immunol Ther Exp (Warsz); 1987; 35(6):795-801. PubMed ID: 3508039
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Familial myasthenia gravis.
    Honeybourne D; Dyer PA; Mohr PD
    J Neurol Neurosurg Psychiatry; 1982 Sep; 45(9):854-6. PubMed ID: 7131024
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Segregation of HLA haplotypes in 100 families with a myasthenia gravis patient.
    van den Berg-Loonen EM; Nijenhuis LE; Engelfriet CP; Feltkamp TE; van Rossum AL; Oosterhuis HJ
    J Immunogenet; 1977 Oct; 4(5):331-40. PubMed ID: 925350
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Antigens of histocompatibility in children with myasthenia gravis].
    Neretin VIa; Serova LD; Agafonov BV; Tsuman VG; Gekht BM; Sidorova OP; Nalivkin AE
    Zh Nevrol Psikhiatr Im S S Korsakova; 2001; 101(7):44-8. PubMed ID: 11523395
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Correlation of thymic pathology with HLA in myasthenia gravis.
    Machens A; Löliger C; Pichlmeier U; Emskötter T; Busch C; Izbicki JR
    Clin Immunol; 1999 Jun; 91(3):296-301. PubMed ID: 10370374
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Familial autoimmune myasthenia gravis.
    Tan JH; Ho KH
    Singapore Med J; 2001 Apr; 42(4):178-9. PubMed ID: 11465320
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Linkage of HLA to myasthenia gravis and genetic heterogeneity depending on anti-titin antibodies.
    Giraud M; Beaurain G; Yamamoto AM; Eymard B; Tranchant C; Gajdos P; Garchon HJ
    Neurology; 2001 Nov; 57(9):1555-60. PubMed ID: 11706089
    [TBL] [Abstract][Full Text] [Related]  

  • 10. HLA genotypes in Turkish patients with myasthenia gravis: comparison with multiple sclerosis patients on the basis of clinical subtypes and demographic features.
    Dönmez B; Ozakbas S; Oktem MA; Gedizlioglu M; Coker I; Genc A; Idiman E
    Hum Immunol; 2004 Jul; 65(7):752-7. PubMed ID: 15301866
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Familial autoimmune myasthenia gravis and thymoma: occurrence in two brothers.
    Pascuzzi RM; Sermas A; Phillips LH; Johns TR
    Neurology; 1986 Mar; 36(3):423-7. PubMed ID: 3951715
    [TBL] [Abstract][Full Text] [Related]  

  • 12. HLA antigens and myasthenia gravis in north India.
    Mehra NK; Ahuja GK; Taneja V; Vaidya MC
    J Neurol Neurosurg Psychiatry; 1983 Apr; 46(4):361-4. PubMed ID: 6842252
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Clinical, pathologic and HLA antigen markers of heterogeneity associated with myasthenia gravis].
    Apostolski S; Krstić S; Gospavić J; Miletić V; Lazić D; Stolić I
    Neurologija; 1985; 34(1-4):47-58. PubMed ID: 3836365
    [No Abstract]   [Full Text] [Related]  

  • 14. Recurrent transverse myelitis, myasthenia gravis, and autoantibodies.
    Lindsey JW; Albers GW; Steinman L
    Ann Neurol; 1992 Sep; 32(3):407-9. PubMed ID: 1416813
    [TBL] [Abstract][Full Text] [Related]  

  • 15. HLA antigens and myasthenia gravis in Japan.
    Yoshida T; Tsuchiya M; Ono A; Yoshimatsu H; Satoyoshi E; Tsuji K
    J Neurol Sci; 1977 Jun; 32(2):195-201. PubMed ID: 874518
    [TBL] [Abstract][Full Text] [Related]  

  • 16. HLA antigens and acetylcholine receptor antibody in the subclassification of myasthenia gravis in Hong Kong Chinese.
    Hawkins BR; Ip MS; Lam KS; Ma JT; Wy CL; Yeung RT; Dawkins RL
    J Neurol Neurosurg Psychiatry; 1986 Mar; 49(3):316-9. PubMed ID: 3958744
    [TBL] [Abstract][Full Text] [Related]  

  • 17. HLA antigens in Japanese patients with myasthenia gravis.
    Matsuki K; Juji T; Tokunaga K; Takamizawa M; Maeda H; Soda M; Nomura Y; Segawa M
    J Clin Invest; 1990 Aug; 86(2):392-9. PubMed ID: 1974553
    [TBL] [Abstract][Full Text] [Related]  

  • 18. HLA antigens and acetylcholine receptor antibodies in penicillamine induced myasthenia gravis.
    Garlepp MJ; Dawkins RL; Christiansen FT
    Br Med J (Clin Res Ed); 1983 Jan; 286(6362):338-40. PubMed ID: 6402089
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Biermer's anemia, Hashimoto's thyroiditis, myasthenia and malignant thymoma. HLA B8, DR3, and DR5 antigens].
    Humbert P; Dupond JL; Mallet H; Leconte des Floris R
    Presse Med; 1984 Feb; 13(7):439. PubMed ID: 6230615
    [No Abstract]   [Full Text] [Related]  

  • 20. Myasthenia gravis and HLA antigens in American blacks and other races.
    Christiansen FT; Pollack MS; Garlepp MJ; Dawkins RL
    J Neuroimmunol; 1984 Dec; 7(2-3):121-9. PubMed ID: 6334696
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.